mRNA |
MG-132 |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.3 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
0.034 |
0.3 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.3 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.3 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
SL 0101-1 |
GDSC1000 |
pan-cancer |
AAC |
0.041 |
0.3 |
mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.3 |